By expenditures
| Name | Title | Type |
|---|---|---|
| Toniann Richard | Chief Financial Officer | Auditee |
| Justin Kensinger | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 375390 | 2025 | 2025-12-17 | FORVIS MAZARS LLP | $5.90M |
| 345945 | 2024 | 2025-03-13 | Forvis Mazars LLP | $6.54M |
| 15605 | 2023 | 2024-02-05 | Forvis LLP | $8.14M |
| 34570 | 2022 | 2023-01-05 | Forvis LLP | $4.80M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 345945 | 2024 | 2025-03-13 | 1103291 | 2024-001 | Material Weakness | - | I |
| 345945 | 2024 | 2025-03-13 | 526849 | 2024-001 | Material Weakness | - | I |
| 15605 | 2023 | 2024-02-05 | 588218 | 2023-002 | Material Weakness | - | C |
| 15605 | 2023 | 2024-02-05 | 588217 | 2023-001 | Significant Deficiency | Yes | N |
| 15605 | 2023 | 2024-02-05 | 588216 | 2023-001 | Significant Deficiency | Yes | N |
| 15605 | 2023 | 2024-02-05 | 588215 | 2023-001 | Significant Deficiency | Yes | N |
| 15605 | 2023 | 2024-02-05 | 11776 | 2023-002 | Material Weakness | - | C |
| 15605 | 2023 | 2024-02-05 | 11775 | 2023-001 | Significant Deficiency | Yes | N |
| 15605 | 2023 | 2024-02-05 | 11774 | 2023-001 | Significant Deficiency | Yes | N |
| 15605 | 2023 | 2024-02-05 | 11773 | 2023-001 | Significant Deficiency | Yes | N |
| 34570 | 2022 | 2023-01-05 | 610220 | 2022-002 | Significant Deficiency | - | N |
| 34570 | 2022 | 2023-01-05 | 610219 | 2022-002 | Significant Deficiency | - | N |
| 34570 | 2022 | 2023-01-05 | 610218 | 2022-002 | Significant Deficiency | - | N |
| 34570 | 2022 | 2023-01-05 | 33778 | 2022-002 | Significant Deficiency | - | N |
| 34570 | 2022 | 2023-01-05 | 33777 | 2022-002 | Significant Deficiency | - | N |
| 34570 | 2022 | 2023-01-05 | 33776 | 2022-002 | Significant Deficiency | - | N |